Comparison between Prophylactic versus Therapeutic Doses of Low-Molecular-Weight Heparin in Severely Ill Coronavirus Disease 2019 Patients in Relation to Disease Progression and Outcome

Comparison between Prophylactic versus Therapeutic Doses of Low-Molecular-Weight Heparin in Severely Ill Coronavirus Disease 2019 Patients in Relation to Disease Progression and Outcome

Introduction: The predominant coagulation abnormalities in patients with coronavirus disease 2019 (COVID-19) suggest a hypercoagulable state and are consistent with uncontrolled clinical observations of an increased risk of venous thromboembolism. Aim and Objectives: To compare the effect of prophyl...

Full description

Bibliographic Details
Main Authors: Ahmed Elmelhat, Essam Elbourai, Hany Dewedar, Taghrid Elgergawi, Maryam Alkhanbouli, Salwa Ahmed, Zoiya Malik, Alaa Nugud, Shadha Mohammed, Hozaifah Mohammad, Abdullah Husain
Format: Article
Language:English
Published: Karger Publishers 2020-10-01
Series:Dubai Medical Journal
Subjects:
covid-19
enoxaparin
pneumonia
coagulopathy
corona
Online Access:https://www.karger.com/Article/FullText/511163

Internet

https://www.karger.com/Article/FullText/511163

Similar Items